DEA and HHS extend virtual prescribing for controlled substances through 2025
The U.S. Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, preventing some patients from losing access to their telehealth-prescribed medications. The agencies…
Continue Reading
